ResearcherJosep Carreras Leukaemia Research InstituteNo recent work listed

Ramón Mangues Bafalluy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2661-9525; OpenAlex author ID A5029892045. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper

Papers 1

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma… Last author DOI 10.1242/dmm.026369 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Francesca Sarno · 1 shared paper, 2016 · strength 0.05
- Paper Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with g… DOI 10.1242/dmm.026369 ↗
María Virtudes Céspedes · 1 shared paper, 2016 · strength 0.05
- Paper Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with g… DOI 10.1242/dmm.026369 ↗
Manuel M. Hidalgo · 1 shared paper, 2016 · strength 0.05
- Paper Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with g… DOI 10.1242/dmm.026369 ↗
Paola Allavena · 1 shared paper, 2016 · strength 0.05
- Paper Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with g… DOI 10.1242/dmm.026369 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.